Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Article
  • Published:

In vivo transfection of a cis element ‘decoy’ against signal transducers and activators of the transcription 6 (STAT6) binding site ameliorates the response of contact hypersensitivity

Abstract

We herein demonstrate that STAT6 plays an important role in the induction of not only acute contact hypersensitivity (CHS), but also chronic CHS in a mouse model using STAT6-deficient (STAT6−/−) mice. We, therefore, determine whether synthetic double-stranded DNA with a high affinity for STAT6 can be introduced in vivo as a decoy cis element to bind the transcriptional factor and block the induction of not only acute CHS but also chronic CHS. Treatment by the transfection of STAT6 decoy oligodeoxynucleotides (ODN), after the induction of 2,4,6-trinitrochlorobenzene or other haptens had a significant inhibitory effect on the induction of both acute CHS and chronic CHS. We thus examined the mechanism of the in vivo effect of the transfection of STAT6 decoy ODN in both acute and chronic CHS. In the histological analysis, the infiltration of eosinophils and degranulated mast cells, and the production of IL-4, IL-6 and eotaxin, but not IFN-γ in the extracts from challenged skin significantly decreased by the transfection of STAT6 decoy ODN. We herein report the first successful in vivo transfer of STAT6 decoy ODN to inhibit acute and chronic CHS, thus providing a new therapeutic strategy not only for the treatment of CHS but also for atopic dermatitis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Xu H, DiIulio NA, Fairchild RL . T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production: interferon gamma-producing (Tc1) effector CD8+ T cells and interleukin (IL)-4/IL-10-producing (Th2) negative regulatory CD4+ T cells. J Exp Med 1996; 183: 1001–1012.

    Article  CAS  Google Scholar 

  2. Steinbrink K, Sorg C, Macher E . Low zone tolerance to contact allergens in mice: a functional role for CD8+ T helper type 2 cells. J Exp Med 1996; 183: 759–768.

    Article  CAS  Google Scholar 

  3. Gautam SC, Chikkala NF, Hamilton TA . Anti-inflammatory action of IL-4. Negative regulation of contact sensitivity to trinitrochlorobenzene. J Immunol 1992; 148: 1411–1415.

    CAS  PubMed  Google Scholar 

  4. Asada H, Linton J, Katz SI . Cytokine gene expression during the elicitation phase of contact sensitivity: regulation by endogeneous IL-4. J Invest Dermatol 1997; 108: 406–411.

    Article  CAS  Google Scholar 

  5. Dieli F et al. IL-4 is essential for the systemic transfer of delayed hypersensitivity by T cell lines. Role of gamma/delta cells. J Immunol 1994; 152: 2698–2704.

    CAS  PubMed  Google Scholar 

  6. Salerno A et al. IL-4 is a critical cytokine in contact sensitivity. Immunology 1995; 84: 404–409.

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Asherson GL et al. Role of IL-4 in delayed type hypersensitivity. Clin Exp Immunol 1996; 103: 1–4.

    Article  CAS  Google Scholar 

  8. Weigmann B et al. Diminished contact hypersensitivity response in IL-4 deficient mice at a late phase of the elicitation reaction. Scand J Immunol 1997; 45: 308–314.

    Article  CAS  Google Scholar 

  9. Takeda K et al. Essential role of Stat6 in IL-4 signaling. Nature 1996; 380: 627–630.

    Article  CAS  Google Scholar 

  10. Yokozeki H et al. Signal transducer and activator of transcription 6 is essential in the induction of contact hypersensitivity. J Exp Med 2000; 191: 995–1004.

    Article  CAS  Google Scholar 

  11. Yokozeki H et al. Gammadelta T cells assist alphabeta T cells in the adoptive transfer of contact hypersensitivity to para-phenylenediamine. Clin Exp Immunol 2001; 125: 351–359.

    Article  CAS  Google Scholar 

  12. Yokozeki H et al. Th2 cytokines, IgE and mast cells play a crucial role in the induction of para-phenylenediamine-induced contact hypersensitivity in mice. Clin Exp Immunol 2003; 132: 385–392.

    Article  CAS  Google Scholar 

  13. Kitagaki H et al. Immediate-type hypersensitivity response followed by a late reaction is induced by repeated epicutaneous application of contact sensitizing agents in mice. J Invest Dermatol 1995; 105: 749–755.

    Article  CAS  Google Scholar 

  14. Kitagaki H et al. Repeated elicitation of contact hypersensitivity induces a shift in cutaneous cytokine milieu from a T helper cell type 1 to a T helper cell type 2 profile. J Immunol 1997; 159: 2484–2491.

    CAS  Google Scholar 

  15. Morishita R et al. Application of transcription factor ‘decoy’ strategy as means of gene therapy and study of gene expression in cardiovascular disease. Circ Res 1998; 82: 1023–1028.

    Article  CAS  Google Scholar 

  16. Morishita R, Aoki M, Kaneda Y . Oligonucleotides-based gene therapy for cardiovascular disease: are oligonucleotide therapeutics novel cardiovascular drugs? Curr Drug Targets 2000; 1: 15–23.

    Article  CAS  Google Scholar 

  17. Morishita R et al. In vivo transfection of cis-element ‘decoy’ against nuclear factor-kappaB binding site prevents myocardial infarction. Nat Med 1997; 3: 894–899.

    Article  CAS  Google Scholar 

  18. Tomita T et al. Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor kappaB decoy oligodeoxynucleotides as a gene therapy. Arthritis Rheum 1999; 42: 2532–2542.

    Article  CAS  Google Scholar 

  19. Kawamura I et al. Intratumoral injection of oligonucleotides to the NF kappaB binding site inhibits cachexia in a mouse tumor model. Gene Therapy 1999; 6: 91–97.

    Article  CAS  Google Scholar 

  20. Tomita N et al. In vivo administration of a nuclear transcription factor-kappaB decoy suppresses experimental crescentic glomerulonephritis. J Am Soc Nephrol 2000; 11: 1244–1252.

    CAS  Google Scholar 

  21. Kawamura I et al. Intravenous injection of oligodeoxynucleotides to the NF-kappaB binding site inhibits hepatic metastasis of M5076 reticulosarcoma in mice. Gene Therapy 2001; 8: 905–912.

    Article  CAS  Google Scholar 

  22. Abeyama K et al. A role of NF-kappaB-dependent gene transactivation in sunburn. J Clin Invest 2000; 105: 1751–1759.

    Article  CAS  Google Scholar 

  23. Nakamura H et al. Prevention and regression of atopic dermatitis by ointment containing NF-kB decoy oligodeoxynucleotides in NC/Nga atopic mouse model. Gene Therapy 2002; 9: 1221–1229.

    Article  CAS  Google Scholar 

  24. Muller KM et al. Th2 cells mediate IL-4-dependent local tissue inflammation. J Immunol 1993; 150: 5576–5584.

    CAS  PubMed  Google Scholar 

  25. Garside P, Mowat AM . Polarization of Th-cell responses: a phylogenetic consequence of nonspecific immune defence? Immunol Today 1995; 16: 220–223.

    Article  CAS  Google Scholar 

  26. Swain SL . Generation and in vivo persistence of polarized Th 1 and Th 2 memory cells. Immunity 1994; 1: 543–552.

    Article  CAS  Google Scholar 

  27. Kaneda Y et al. Hemagglutinating virus of Japan (HVJ) envelope vector as a versatile gene delivery system. Mol Ther 2002; 6: 219–226.

    Article  CAS  Google Scholar 

  28. Malaviya R, Uckun FM . Role of STAT6 in IgE receptor/FcepsilonRI-mediated late phase allegic responses of mast cells. J Immunol 2002; 168: 421–426.

    Article  CAS  Google Scholar 

  29. Hoeck J, Woisetschlager M . Activation of eotaxin-3/CCLI26 gene expression in human dermal fibroblasts is mediated by STAT6. J Immunol 2001; 167: 3216–3222.

    Article  CAS  Google Scholar 

  30. Hoeck J, Woisetschlager M . STAT6 mediates eotaxin-1 expression in IL-4 or TNF-alpha-induced fibroblasts. J Immunol 2001; 166: 4507–4515.

    Article  CAS  Google Scholar 

  31. Wang LH et al. Targeted disruption of stat6 DNA binding activity by an oligonucleotide decoy blocks IL-4-deriven T(H)2 cell response. Blood 2000; 95: 1249–1257.

    CAS  PubMed  Google Scholar 

  32. Molitor JA et al. NF-kappaB. A family of inducible and differentially expressed enhancer-binding proteins in human T cells. Proc Natl Acad Sci USA 1990; 87: 10028–10032.

    Article  CAS  Google Scholar 

  33. Schreiber E et al. Rapid detection of octamer binding proteins with ‘mini-extracts’, prepared from a small number of cells. Nucleic Acids Res 1989; 17: 6419.

    Article  CAS  Google Scholar 

  34. Ferguson TA, Dube P, Griffith TS . Regulation of contact hypersensitivity by interleukin 10. J Exp Med 1994; 179: 1597–1604.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Ms Motoko Sekiya for her excellent technical assistance.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sumi, K., Yokozeki, H., Wu, MH. et al. In vivo transfection of a cis element ‘decoy’ against signal transducers and activators of the transcription 6 (STAT6) binding site ameliorates the response of contact hypersensitivity. Gene Ther 11, 1763–1771 (2004). https://doi.org/10.1038/sj.gt.3302345

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3302345

Keywords

This article is cited by

Search

Quick links